Halda Therapeutics

NEW HAVEN, CT · Founded 2018 · CIK 0001769401 · Biotech · Acquired

Bifunctional small molecule therapeutics for cancer

haldatx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$198M
4 Form D · Aug 2024
26 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$6,250,743
Private capital raisedForm D · SEC$40,990,001
Private capital raisedForm D · SEC$24,211,678
Private capital raisedForm D · SEC$126,471,316
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2397Antiva Biosciences—$81M
2398Fate Therapeutics—$236M
2399COLORADO RESEARCH PARTNERS, LLC——
2400Halda Therapeutics—$198M
2401MCM6 THERAPEUTICS, INC.——
2402IZON Technologies, LLC—$1.0M
2403Alchemab——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Joe CabralDirector
  • Rebecca FreyDirector
  • Arjun GoyalDirector
  • Rebecca LuseDirector
  • Scott PhillipsExecutive Officer
  • Liam RatcliffeDirector
  • Nandita ShangariDirector
  • Tim ShannonDirector · Executive Officer
  • Leyi WangDirector
  • Wei ZhaoDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.